Ductal carcinoma in situ of breast: update 2019

Research output: Contribution to journalReview article

Abstract

Ductal carcinoma in situ is a non-invasive form of breast cancer. Its incidence is increasing due to widespread use of mammographic screening. It presents several diagnostic and management challenges in part due to its relatively indolent behaviour. Most series analysing biomarkers in these lesions are small (<100 patients) and large clinical trials have not been frequent. Herein, we review the recent progress made in understanding the biology of this entity and the tools available for prognostication.

Original languageEnglish (US)
JournalPathology
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Carcinoma, Intraductal, Noninfiltrating
Breast
Biomarkers
Clinical Trials
Breast Neoplasms
Incidence

Keywords

  • Breast cancer
  • DCIS
  • ductal carcinoma in situ
  • molecular features
  • pathology

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Ductal carcinoma in situ of breast : update 2019. / Badve, Sunil; Polar, Yesim.

In: Pathology, 01.01.2019.

Research output: Contribution to journalReview article

@article{1f79d8c40de94179a0f7235f3591c24d,
title = "Ductal carcinoma in situ of breast: update 2019",
abstract = "Ductal carcinoma in situ is a non-invasive form of breast cancer. Its incidence is increasing due to widespread use of mammographic screening. It presents several diagnostic and management challenges in part due to its relatively indolent behaviour. Most series analysing biomarkers in these lesions are small (<100 patients) and large clinical trials have not been frequent. Herein, we review the recent progress made in understanding the biology of this entity and the tools available for prognostication.",
keywords = "Breast cancer, DCIS, ductal carcinoma in situ, molecular features, pathology",
author = "Sunil Badve and Yesim Polar",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.pathol.2019.07.005",
language = "English (US)",
journal = "Pathology",
issn = "0031-3025",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Ductal carcinoma in situ of breast

T2 - update 2019

AU - Badve, Sunil

AU - Polar, Yesim

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Ductal carcinoma in situ is a non-invasive form of breast cancer. Its incidence is increasing due to widespread use of mammographic screening. It presents several diagnostic and management challenges in part due to its relatively indolent behaviour. Most series analysing biomarkers in these lesions are small (<100 patients) and large clinical trials have not been frequent. Herein, we review the recent progress made in understanding the biology of this entity and the tools available for prognostication.

AB - Ductal carcinoma in situ is a non-invasive form of breast cancer. Its incidence is increasing due to widespread use of mammographic screening. It presents several diagnostic and management challenges in part due to its relatively indolent behaviour. Most series analysing biomarkers in these lesions are small (<100 patients) and large clinical trials have not been frequent. Herein, we review the recent progress made in understanding the biology of this entity and the tools available for prognostication.

KW - Breast cancer

KW - DCIS

KW - ductal carcinoma in situ

KW - molecular features

KW - pathology

UR - http://www.scopus.com/inward/record.url?scp=85071340055&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071340055&partnerID=8YFLogxK

U2 - 10.1016/j.pathol.2019.07.005

DO - 10.1016/j.pathol.2019.07.005

M3 - Review article

AN - SCOPUS:85071340055

JO - Pathology

JF - Pathology

SN - 0031-3025

ER -